Литература

1. Selye H. Stress in health and disease. Butterworth Inc. 1976.

2. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. American Psychiatric Association, Washington, DC; 1987.

3. Hamilton M. A rating scale for depression. J Neural Neurosurg Psychiatry. 1960; 23: 55-62.

4. Selye H. The Physiology and Pathology of Exposure to Stress. Montreal, Canada: Acta Inc; 1950.

5. Bateman A, Singh A, Krai T, et al. The immunohypothalamic-pitu-itary-adrenal axis. Endocrinol Rev. 1989; 10: 92-112.

6. Whitcomb RW, Unehan WM, Wahl LM, Knazek RA. Monocytes stimulate cortisol production by cultured human adrenocortical cells. J Clin Endocrinol Metab. 1988; 66: 33-38.

7. Murphy ВЕР. Steroids and depression. J Steroid Biochem Mol Biol. 1991; 38: 537-559.

8. Cairns M, Goodman BM, Lent SJ, et al. High intensity venous sam­pling of plasma ACTH: preliminary observations in normal and depressed subjects. Proceedings of the XXIIIrd Annual Meeting of the International Society of Psychoneuroendocrinology, Madison, WI, Aug 16-20, 1992: 72.

9. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB. Cerebrospinal fluid corticotropinreleasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry. 1987; 144: 873-877.

10. Bondy PK. Disorders of the adrenal cortex. Chapter 22 in Williams' Textbook of Endocrinology. JD Wilson, DW Foster, eds. WB Saunders Co; 1985: 861-862.

11. Gold PW, Loriaux DL, Roy A, et al. Responses to corticotropin­releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engi J Med. 1986; 314: 1329-1335.

12. Asa SL, Kovacs К, Tindall GT, Barrow DL, Horvath E, Takef Y. CRF-producing hypothalamic gangliocytoma associated with pituitary

corticotrophic cell hyperplasia: evidence for a hypothalamic etiology of Cushing's disease. Program of the 65th Annual Meeting of the Endocrine Society, San Antonio, Tx, June 8-10, 1983. № 441, p 191.

13. Murphy ВЕР. Treatment of major depression with steroid suppres-sive drugs. / Steroid Biochem. Mol Biol. 1991; 39: 239-244.

14. Nair NPV, Sharma M. Neurochemical and receptor theories of depression. Psychlatr J Univ Ottawa. 1989; 14; 328-341. ' .

15. Peiffer A, Veilleux S, Barden N. Antidepressant and other cen­trally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 1991; 16: 505-515.

16. Sapolsky RM, Krey LC, McEwen BS. Stress down-regulates corti-costerone receptors in a sitespecific manner in the brain. Endocrinology. 1984; 114: 287-292.

17. de Montigny С, Chaput Y, Blier P. Lithium augmentation of anti-depressant treatments: evidence tor the involvement of the 5-HT sys­tem? In: Briley M, Filion G, eds. New Concepts in Depression. London:

MacMillan Press; 1988.

18. Whalley LJ, Eagles JM, Bowler GNR et al. Selective effects of ЕСТ on hypothalamic-pituitary activity. Psychol Med. 1987; 17; 319-328.

19. Murphy ВЕР, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant 4o anti-depressant therapy. J Clin Psychopharmacol. 1991; 11: 121-126.

20. Murphy ВЕР, Dhar V, Ghadirian AM, Fillpini D, Keller R, Chouinard G. Endocrine and psychiatric responses to inhibitors of steroid biosynthesis in patients with antidepressant-resistant major depression. Proceedings of the XXIIIrd Annual Meeting of the International Society of Psychoneuroendocrinology, Madison, WI, Aug 16-20. 1992.

Стресс и тревожно-депрессивные синдромы — В. E. Pearson Murphy